We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
-15.35%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$95.5M
AUM Growth
-$40.1M
Cap. Flow
+$254M
Cap. Flow %
266.32%
Top 10 Hldgs %
44.8%
Holding
389
New
183
Increased
50
Reduced
47
Closed
99

Top Buys

1
REGN icon
Regeneron Pharmaceuticals
REGN
+$10.6M
2
BAX icon
Baxter International
BAX
+$3.81M
3
AKBA icon
Akebia Therapeutics
AKBA
+$2.87M
4
OTIC
Otonomy, Inc.
OTIC
+$2.46M
5
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$1.81M

Top Sells

1
GILD icon
Gilead Sciences
GILD
+$8.82M
2
CELG
Celgene Corp
CELG
+$6.57M
3
DYAX
DYAX CORPORATION
DYAX
+$6.35M
4
CMG icon
Chipotle Mexican Grill
CMG
+$5.44M
5
VTRS icon
Viatris
VTRS
+$2.57M

Sector Composition

1 Healthcare 48.43%
2 Technology 4.06%
3 Consumer Discretionary 2.5%
4 Consumer Staples 1.74%
5 Materials 1.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
YUM icon
351
PUT
Yum! Brands
YUM
$41.9B
– –
-41,730
Closed -$56K
SIOX
352
PUT
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
– –
-4,263
Closed -$140K
MXIM
353
DELISTED
Maxim Integrated Products
MXIM
– –
-8,500
Closed -$285K
MXIM
354
PUT
DELISTED
Maxim Integrated Products
MXIM
– –
-19,700
Closed -$21K
TIF
355
DELISTED
Tiffany & Co.
TIF
– –
-7,129
Closed -$478K
AGN
356
PUT
DELISTED
Allergan plc
AGN
– –
-44,000
Closed -$37K
ALDR
357
CALL
DELISTED
Alder Biopharmaceuticals
ALDR
– –
-5,000
Closed -$7K
P
358
DELISTED
Pandora Media Inc
P
– –
-16,000
Closed -$215K
P
359
PUT
DELISTED
Pandora Media Inc
P
– –
-16,000
Closed -$260K
FMI
360
DELISTED
Foundation Medicine, Inc.
FMI
– –
-13,387
Closed -$216K
FMI
361
PUT
DELISTED
Foundation Medicine, Inc.
FMI
– –
-5,000
Closed -$15K
NSM
362
DELISTED
Nationstar Mortgage Holdings
NSM
– –
-9,200
Closed -$123K
NSM
363
PUT
DELISTED
Nationstar Mortgage Holdings
NSM
– –
-9,200
Closed -$234K
SYT
364
CALL
DELISTED
Syngenta Ag
SYT
– –
-2,500
Closed -$13K
SYT
365
DELISTED
Syngenta Ag
SYT
– –
-10,294
Closed -$810K
SYT
366
PUT
DELISTED
Syngenta Ag
SYT
– –
-10,700
Closed -$11K
CEMP
367
CALL
DELISTED
Cempra, Inc.
CEMP
– –
-25,400
Closed -$19K
BHI
368
DELISTED
Baker Hughes
BHI
– –
-13,066
Closed -$564K
BHI
369
PUT
DELISTED
Baker Hughes
BHI
– –
-21,300
Closed -$126K
RLYP
370
PUT
DELISTED
RELYPSA INC COM
RLYP
– –
-5,000
Closed -$19K
GMCR
371
CALL
DELISTED
KEURIG GREEN MTN INC
GMCR
– –
-13,900
Closed -$476K
GMCR
372
DELISTED
KEURIG GREEN MTN INC
GMCR
– –
-7,710
Closed -$694K
GMCR
373
PUT
DELISTED
KEURIG GREEN MTN INC
GMCR
– –
-8,000
Closed -$254K
BRCM
374
CALL
DELISTED
BROADCOM CORP CL-A
BRCM
– –
-33,400
Closed -$108K
BRCM
375
PUT
DELISTED
BROADCOM CORP CL-A
BRCM
– –
-19,900
Closed -$114K
12 13 14
15
16

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q1 2016 Portfolio in Review

As of Q1 2016, FT Options held 389 positions worth $95.5M, down 30% from $136M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

FT Options deployed $254M of net new capital in Q1 2016, opening 183 new positions and adding to 50 existing holdings. Its largest new stake was Baxter International: 100,000 shares worth $4.11M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 43% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Gilead Sciences, an estimated $8.82M trimmed.

  • FT Options's largest Q1 2016 buy was Baxter International: 100,000 shares worth $4.11M.
  • FT Options added most to Regeneron Pharmaceuticals in Q1 2016, an estimated $10.6M increase.
  • FT Options's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $8.82M.
  • FT Options fully exited Celgene Corp in Q1 2016, selling an estimated $6.57M.
  • FT Options's ten largest holdings make up 45% of its $95.5M portfolio in Q1 2016.
  • FT Options opened 183 new positions and closed 99 in Q1 2016.
  • FT Options's portfolio value fell 30% quarter-over-quarter to $95.5M.

Based on FT Options's 13F filing for Q1 2016, filed 9 May 2016.